About Us

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.

Learn more


The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.